Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Eur J Neurosci. 2008 Feb;27(4):791–800. doi: 10.1111/j.1460-9568.2008.06073.x

Fig. 1.

Fig. 1

(A) The mean (± SEM) number of 5-bromo-2′-deoxyuridine-5′-monophosphate (BrdU)+ cells in the rostral CA1 of PND4 males and females treated with vehicle (Veh), testosterone (T), flutamide (FLU), the combination of T and FLU (T/FLU), or dihydrotestosterone (DHT) on PND0 and 1, and BrdU on PND1–4. Groups with different letters are significantly different from each other (ANOVA, P < 0.05). (B) The mean (± SEM) number of BrdU+ cells in the rostral dentate gyrus (DG) of the same animals as in (A). Groups with different letters are significantly different from each other (ANOVA, P < 0.05). (C) The mean (± SEM) number of BrdU+ cells in the ventromedial hypothalamus (VMH) of the same animals. There were no statistically significant differences between groups. The n/group is indicated in the bar for VMH but applies to all brain regions.